Provided by Tiger Trade Technology Pte. Ltd.

MABPHARM-B

0.510
0.000
Volume:- -
Turnover:- -
Market Cap:2.10B
PE:-16.44
High:0.510
Open:0.510
Low:0.510
Close:0.510
52wk High:0.940
52wk Low:0.280
Shares:4.12B
HK Float Shares:4.12B
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.031
ROE:-25.68%
ROA:-1.48%
PB:18.78
PE(LYR):-16.44
PS:4.38

Loading ...

Mabpharm (2181) Issues Reminder on Electronic Dissemination of Corporate Communications

Bulletin Express
·
Feb 10

Mabpharm Limited (2181) Reminds Shareholders of Electronic Dissemination Arrangements

Bulletin Express
·
Feb 10

Mabpharm (02181) Announces January 2026 Monthly Return

Bulletin Express
·
Feb 03

Insiders the biggest winners as Mabpharm Limited's (HKG:2181) market cap rises to HK$2.3b

Simply Wall St.
·
Jan 10

Mabpharm Ltd. Moves Hong Kong Office to Chuang's Tower

Reuters
·
Dec 05, 2025

Mabpharm Limited (02181) Publishes Monthly Return for November 2025

Bulletin Express
·
Dec 03, 2025

Mabpharm (2181) Updates Nomination Committee Terms of Reference

Bulletin Express
·
Oct 31, 2025

Mabpharm Limited (2181) Announces Board Composition and Committee Arrangements

Bulletin Express
·
Oct 31, 2025

Mabpharm Limited (2181) Announces Lead INED Designation and Nomination Committee Changes

Bulletin Express
·
Oct 31, 2025

MABPHARM-B (02181): Dr. Zhang Yanyun Appointed as Lead Independent Non-Executive Director

Stock News
·
Oct 31, 2025

Mabpharm Appoints Lead Independent Director and Updates Nomination Committee

Reuters
·
Oct 31, 2025

Mabpharm Ltd. files director list with HKEX

Reuters
·
Oct 31, 2025

MABPHARM-B (02181) Reports Interim Results with Shareholders' Attributable Profit of RMB 2.898 Million, Turning from Loss to Profit Year-over-Year

Stock News
·
Aug 28, 2025

Mabpharm Ltd. Reports 152.7% Revenue Surge and Returns to Profit with RMB 2,898,000 Net Income for H1 2025

Reuters
·
Aug 28, 2025

Mabpharm H1 Revenue RMB 270 Million

THOMSON REUTERS
·
Aug 28, 2025